Trial Outcomes & Findings for Learning Alerts for Acute Kidney Injury (NCT NCT02786277)

NCT ID: NCT02786277

Last Updated: 2025-10-08

Results Overview

Progression of AKI is defined as the increase in KDIGO stage from the time of randomization to the present. For patients who are discharged, we will impute 14-day creatinine using the last observation carried forward method. Dialysis is defined as the receipt of hemodialysis, continuous renal replacement therapy, or peritoneal dialysis. Isolated ultrafiltration treatments will not be included. Mortality will be determined from hospital administrative records.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

2046 participants

Primary outcome timeframe

Within 14 days from randomization

Results posted on

2025-10-08

Participant Flow

Recruitment occurred at 4 hospital sites across the Yale New Haven Hospital System. Identification of eligible patient subjects was performed within the Epic electronic medical record system based on inclusion and exclusion criteria by an algorithm embedded into the best practice alert. Randomization occurred the moment the best practice build identified a patient as being eligible.

Participant milestones

Participant milestones
Measure
Recommended
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Overall Study
STARTED
1002
1044
Overall Study
COMPLETED
1002
1044
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Learning Alerts for Acute Kidney Injury

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Total
n=2046 Participants
Total of all reporting groups
Age, Continuous
64.5 Years
n=5 Participants
63.2 Years
n=7 Participants
63.7 Years
n=5 Participants
Sex/Gender, Customized
Female
537 Participants
n=5 Participants
503 Participants
n=7 Participants
1040 Participants
n=5 Participants
Race/Ethnicity, Customized
Black
188 Participants
n=5 Participants
206 Participants
n=7 Participants
394 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic or Latino
108 Participants
n=5 Participants
140 Participants
n=7 Participants
248 Participants
n=5 Participants
Creatinine mg/dL
1.5 mg/dL
n=5 Participants
1.5 mg/dL
n=7 Participants
1.5 mg/dL
n=5 Participants
Diastolic blood pressure (mmHg)
67 mmHg
n=5 Participants
68 mmHg
n=7 Participants
68 mmHg
n=5 Participants
Pulse (bpm)
80 beats per minute
n=5 Participants
80 beats per minute
n=7 Participants
80 beats per minute
n=5 Participants
Peripheral Capillary Oxygen Saturation (SpO2, %)
97 percent oxygen saturation
n=5 Participants
97 percent oxygen saturation
n=7 Participants
97 percent oxygen saturation
n=5 Participants
Systolic blood pressure (mmHg)
118 mmHg
n=5 Participants
118 mmHg
n=7 Participants
118 mmHg
n=5 Participants

PRIMARY outcome

Timeframe: Within 14 days from randomization

Progression of AKI is defined as the increase in KDIGO stage from the time of randomization to the present. For patients who are discharged, we will impute 14-day creatinine using the last observation carried forward method. Dialysis is defined as the receipt of hemodialysis, continuous renal replacement therapy, or peritoneal dialysis. Isolated ultrafiltration treatments will not be included. Mortality will be determined from hospital administrative records.

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Proportion of Patients With Progression to a Higher Stage of AKI OR Dialysis OR Death
190 Participants
193 Participants

SECONDARY outcome

Timeframe: Assessed from point of randomization to date of death within 14 days of randomization

Proportion of patients who expire from any cause

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
14-day Mortality
72 Participants
58 Participants

SECONDARY outcome

Timeframe: Assessed from point of randomization to date of death from any cause, up to one year post-randomization

Proportion of patients who expire from any cause

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Inpatient Mortality
169 Participants
185 Participants

SECONDARY outcome

Timeframe: Assessed from point of randomization to date of first documented dialysis order, within 14 days of randomization

Proportion of patients who receive dialysis (hemodialysis, continuous renal replacement therapy, or peritoneal dialysis)

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
14-day Dialysis
38 Participants
37 Participants

SECONDARY outcome

Timeframe: Assess from point of randomization to date of first documented dialysis order during index hospitalization, up to one year post-randomization

Proportion of patients who receive dialysis (hemodialysis, continuous renal replacement therapy, or peritoneal dialysis)

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Inpatient Dialysis
39 Participants
41 Participants

SECONDARY outcome

Timeframe: Assessed at point of discharge from index hospitalization, up to one year post-randomization

Assessed as active orders for dialysis at point of discharge from index hospitalization

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Discharge on Dialysis
28 Participants
22 Participants

SECONDARY outcome

Timeframe: Assessed from the date of randomization to 14 days post randomization

Progression to Stage 2 AKI is defined as a doubling of serum creatinine between randomization and 14 days post randomization, and is considered a worsening of AKI.

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Progression to Stage 2 AKI
91 Participants
103 Participants

SECONDARY outcome

Timeframe: Assessed from the date of randomization to 14 days post randomization

Progression to Stage 3 AKI is defined as a tripling of serum creatinine between the date of randomization and 14 days post randomization, and is considered a worsening of AKI.

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Progression to Stage 3 AKI
72 Participants
66 Participants

SECONDARY outcome

Timeframe: Assessed from the date of randomization to the cessation of AKI during index hospitalization, up to one year

Defined as the time in hours between AKI onset and AKI cessation during index hospitalization

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Duration of AKI
26.9 Hours
Interval 22.5 to 50.1
27.7 Hours
Interval 22.3 to 50.6

SECONDARY outcome

Timeframe: Assessed from discharge date of index hospitalization to 30 days post discharge date

Proportion of patients with readmission within 30 days of index hospitalization discharge

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
30 Day Readmission Rate
123 Participants
187 Participants

SECONDARY outcome

Timeframe: Assessed from point of randomization to date of discharge from index hospitalization, up to one year

Population: The data for this outcome were not collected and will not be accessed in the future. During outcome assessment, PIs were unable to get access to financial data to assess this outcome due to lack of institutional approval, therefore, no participants were analyzed. As this is the only financial-based outcome of the trial, this is the only outcome affected by this circumstance.

Total cost of index hospitalization

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Assessed from date of randomization to date of discharge from index hospitalization, up to one year

Proportion of patients with chart documentation of AKI as assessed by post-discharge ICD-10 codes

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Chart Documentation of AKI
442 Participants
505 Participants

SECONDARY outcome

Timeframe: 24 hours from randomization to discharge, up to one year post randomization

Contrast administration (de novo order of IV contrast agent within 24 hours of randomization), fluid administration (within 24 hours of randomization), aminoglycoside administration (de novo order within 24 hours of randomization), NSAID administration/cessation (de novo order or cessation of order/absence of de novo order of NSAID within 24 hours of randomization), ACE inhibitor administration/cessation, urinalysis order (with or without microscopy within 24 hours of randomization), documentation of AKI (by ICD-9 and ICD-10 codes during index hospitalization), monitoring of creatinine (at least one serum creatinine measurement within 36 hours of randomization), documentation of urine output (within 24 hours of randomization), renal consult order during index hospitalization. Each metric is binary. Outcome is reported as a composite best practice outcome representing the proportion of best practices achieved per subject.

Outcome measures

Outcome measures
Measure
Recommended
n=1002 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Anti-recommended
n=1044 Participants
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert. Alert: An alert informing the provider of the presence of acute kidney injury will be fired.
Proportion of AKI "Best Practices" Achieved Per Subject During Index Hospitalization
.6 Proportion achieved per subject
Interval 0.5 to 0.7
.6 Proportion achieved per subject
Interval 0.5 to 0.7

Adverse Events

Recommended

Serious events: 0 serious events
Other events: 0 other events
Deaths: 169 deaths

Anti-recommended

Serious events: 0 serious events
Other events: 0 other events
Deaths: 185 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

F. Perry Wilson

Yale University

Phone: 203-737-1704

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place